23 Jun Tony Hitchcock Joins the Novel Biotechnology Advisor Board
Tony has over 39 years’ experience in the development of manufacturing process and production of investigational biotherapeutics, 29 of these years, have been predominantly spent in the field of gene therapy and has been in the development of manufacturing processes for 4 licensed products including 3 gene therapy products. Including the development of platform production processes for plasmid DNA, which has been used to produce plasmid DNA for a multiple direct and vector-based therapies.
For the last 25 years he has worked in the contract manufacturing area and have worked on over 30+ products going in the clinical trials, engaging with a worldwide customer bases, which has ranged from virtual to multinational companies.
He has held a number of senior roles with my most recent employer, Charles River Laboratories (formerly Cobra Biologics), managing, tech transfer, manufacturing and development activities for the production of a wide range of clinical entities and recently established himself as an independent consultant supporting developers, supplier and manufacturers in the gene therapy area.